Alzheimer's: Few people in early stages are eligible for new drugs - Medical News Today
medicalnewstoday.comSubmitted by medicalnewstoday7131 in health
Researchers say most people with early Alzheimer's are not eligible to be treated with two newly approved monoclonal antibody drugs, lecanemab and aducanumab